Dr. Yu received her B.S. in Chemical Engineering in 2003 from National Taiwan University, Taiwan, R.O.C and Ph.D. in 2008 from UC Berkeley/UC San Francisco Joint Graduate Group in Bioengineering. Dr. Yu worked as a postdoctoral researcher at UCSF Medical School and Cardiovascular Research Institute from 2008-2010. She relocated back to her alma mater in 2010 and was an Assistant Professor from 2010-2015 and Associate Professor from 2015-2019. Dr Yu is promoted to full Professor from Aug. 2019.
Dr. Yu’s group focus on customized and functional modification of biomaterials including surface modification of biomaterials to enhance cell and extracellular matrix (ECM) interaction. Antibody and peptides conjugated nanoparticles as biosensors and drug delivery vehicles for cancer therapy, cell encapsulation and 3D culture in various porous scaffold and hydrogel for stem cells differentiation. The group has representative publications in Biomaterials, Tissue Engineering, ACS Applied Materials and Interfaces, Journal of Materials Chemistry B and Biomaterials Sciences etc. Dr. Yu serves as the editorial board members of Physics and Chemistry of Stem Cells (Walter de Gruyter, German) and Am J Tissue Eng & Stem Cell (Columbia International Publishing, USA), Frontiers in Materials, Frontiers in Bioengineering (Frontiers, Switzerland) . She is the Associate Editor of Acta Cardiologica Sinica and Fronteirs in Bioengineering.
 

Jiashing Yu’s lab focuses on the development of innovative biomaterials for biomedical applications, with a strong emphasis on hydrogels, polymer chemistry, and nanomedicine. The lab integrates principles of materials science, chemistry, and bioengineering to design functional biomaterials for drug delivery, tissue engineering, and biosensing.

A major research direction involves the design and chemical modification of polymers to enhance their mechanical properties, biocompatibility, and bioactivity. The lab engineers stimuli-responsive hydrogels for controlled drug release, wound healing, and regenerative medicine. These advanced hydrogels can be tailored for injectable therapies, 3D bioprinting, and smart biomedical devices.

Additionally, the lab explores nanomedicine and drug delivery systems, leveraging polymeric nanoparticles, liposomes, and metal-organic frameworks (MOFs) for targeted and efficient drug transport. Special attention is given to dual drug delivery strategies, nanocarriers for precision medicine, and surface-functionalized materials for improved therapeutic outcomes.